Sankara Nethralaya

临床试验

计划入组 18 人 · 首次发布于 2010 年 12 月 9 日

已完成

NCT01701635

SANKOFA Pediatric HIV Disclosure Intervention

计划入组 446 人 · 首次发布于 2012 年 10 月 5 日

已完成

NCT01546389

Sanaria™ PfSPZ Challenge Vaccine

计划入组 30 人 · 首次发布于 2012 年 3 月 7 日

药物

查看全部 23 →

Biotech

Approved

Modified vaccinia ankara(Jynneos)

相关疾病：Ebola Virus Disease, Monkeypox，另有 1 项

SPZ (Sanaria)

Human haemoglobin(Sangart)

机构

查看全部 30 →

NARAYANA NETHRALAYA

India

SANKARA EYE HOSPITAL

India

NARAYANA NETHRALAYA FOUNDATION

India

资讯

查看全部 33 →

2个月前

Macrophage-Like Cells Emerge as Dynamic Biomarker for Tracking Diabetic Macular Edema Treatment Response

6个月前

Sanara MedTech's CellerateRX Surgical Powder Shows $3,852 Cost Savings Per Patient in Spine Surgery Study

去年

临床试验

Modified Vaccinia Ankara (MVA) Vaccine Study

SANKOFA Pediatric HIV Disclosure Intervention

Sanaria™ PfSPZ Challenge Vaccine

药物

Modified vaccinia ankara(Jynneos)

SPZ (Sanaria)

Human haemoglobin(Sangart)

机构

NARAYANA NETHRALAYA

SANKARA EYE HOSPITAL

NARAYANA NETHRALAYA FOUNDATION

资讯

Macrophage-Like Cells Emerge as Dynamic Biomarker for Tracking Diabetic Macular Edema Treatment Response

Sanara MedTech's CellerateRX Surgical Powder Shows $3,852 Cost Savings Per Patient in Spine Surgery Study

Syntara Receives FDA Guidance for Amsulostat Phase 2 Trial in Myelofibrosis